Diabetes and dyslipidemia: characterizing lipoprotein metabolism
GH Tomkin,1,2 D Owens1,2 1Diabetes Institute of Ireland, Beacon Hospital, 2Trinity College, University of Dublin, Dublin, Ireland Abstract: Premature atherosclerosis in diabetes accounts for much of the decreased life span. New treatments have reduced this risk considerably. This review explores the...
Guardado en:
Autores principales: | Tomkin GH, Owens D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b09564257c546a59438a0c394a77c8c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Detection of Low Density Lipoprotein—Comparison of Electrochemical Immuno- and Aptasensor
por: Daria Rudewicz-Kowalczyk, et al.
Publicado: (2021) -
Morphometric analysis of the growth factors influence on fibroblastic phase of inflammation at experimental myocardial infraction
por: M. G. Shurygin, et al.
Publicado: (2014) -
Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
por: Alberto Zambon
Publicado: (2020) -
The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu W, et al.
Publicado: (2020) -
Transition Patterns of Weight Status and Their Predictive Lipid Markers Among Chinese Adults: A Longitudinal Cohort Study Using the Multistate Markov Model
por: Tang X, et al.
Publicado: (2021)